| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | FLNA FLNB FLNC SHROOM3 WASHC1 ACTN4 LASP1 GSN WASH3P AFAP1 PLEC CAP1 MYBPC1 | 6.40e-05 | 479 | 149 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | FK506 binding | 8.53e-05 | 12 | 149 | 3 | GO:0005528 | |
| GeneOntologyMolecularFunction | macrolide binding | 1.40e-04 | 14 | 149 | 3 | GO:0005527 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulator activity | 3.06e-04 | 18 | 149 | 3 | GO:0035014 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.11e-04 | 227 | 149 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | oxygen sensor activity | 5.45e-04 | 5 | 149 | 2 | GO:0019826 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | LGMN FLNA FLNB FLNC SHROOM3 HSPH1 WASHC1 ACTN4 LASP1 AGBL5 EPB41L4A GSN KRIT1 WASH3P AFAP1 NF1 PLEC CAP1 MYBPC1 | 5.45e-04 | 1099 | 149 | 19 | GO:0008092 |
| GeneOntologyBiologicalProcess | actin filament-based process | FLNA FLNB CACNA2D1 FLNC SHROOM3 SFRP1 DSG2 WASHC1 NOX4 ACTN4 EPB41L4A GSN WASH3P NF1 BRAF PIK3R1 PLEC PARD3 PHLDB2 CAP1 MYBPC1 | 2.32e-06 | 912 | 148 | 21 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | FLNA FLNB FLNC SHROOM3 SFRP1 WASHC1 NOX4 ACTN4 EPB41L4A GSN WASH3P NF1 BRAF PIK3R1 PLEC PHLDB2 CAP1 MYBPC1 | 1.87e-05 | 803 | 148 | 18 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | EPHB6 GP6 ILDR2 FLNA SFRP1 CBLL2 HSPH1 DAB1 MDGA2 PTPN22 ACTN4 ST3GAL4 ACTL6A YES1 NF1 BRAF PIK3R1 PRKCA PHLDB2 | 3.69e-05 | 927 | 148 | 19 | GO:0030155 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | FKBP10 FLNA FLNC SHROOM3 SFRP1 COL12A1 WASHC1 NOX4 ACTN4 GSN WASH3P NF1 BRAF PIK3R1 LTBP2 PLEC PHLDB2 CAP1 MYBPC1 | 5.66e-05 | 957 | 148 | 19 | GO:0097435 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 5.87e-05 | 239 | 148 | 9 | GO:0031032 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 6.51e-05 | 59 | 148 | 5 | GO:0045671 | |
| GeneOntologyBiologicalProcess | actin filament organization | FLNA SHROOM3 SFRP1 WASHC1 NOX4 ACTN4 GSN WASH3P BRAF PIK3R1 PLEC PHLDB2 CAP1 | 7.96e-05 | 509 | 148 | 13 | GO:0007015 |
| GeneOntologyBiologicalProcess | negative regulation of protein phosphorylation | SFRP1 SPINK1 PTPN22 JUN NF1 PRKCA PLEC PARD3 QARS1 NNT PAQR3 | 8.58e-05 | 375 | 148 | 11 | GO:0001933 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB6 GP6 ILDR2 FLNA DSG2 HSPH1 DAB1 MDGA2 PTPN22 ST3GAL4 ACTL6A YES1 MMP24 FAT2 PIK3R1 SLITRK5 PRKCA DLG3 LRRC7 PARD3 | 8.95e-05 | 1077 | 148 | 20 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of phosphorylation | SFRP1 SPINK1 PTPN22 JUN NF1 PRKCA PLEC PARD3 QARS1 NNT PAQR3 | 1.55e-04 | 401 | 148 | 11 | GO:0042326 |
| GeneOntologyCellularComponent | anchoring junction | ILDR2 FLNA FLNB FLNC SHROOM3 DSG2 NOX4 ACTN4 LASP1 YES1 GSN KRIT1 FAT2 PTPN12 AFAP1 PIK3R1 PRKCA DLG3 LRRC7 PLEC PARD3 PHLDB2 CAP1 | 6.23e-07 | 976 | 152 | 23 | GO:0070161 |
| GeneOntologyCellularComponent | cell cortex | FLNA FLNB ARHGAP32 SHROOM3 WASHC1 FIGNL2 ACTN4 LASP1 GSN WASH3P PARD3 PHLDB2 CAP1 | 3.34e-06 | 371 | 152 | 13 | GO:0005938 |
| GeneOntologyCellularComponent | focal adhesion | FLNA FLNB FLNC NOX4 ACTN4 LASP1 YES1 GSN PTPN12 AFAP1 PLEC PHLDB2 CAP1 | 1.66e-05 | 431 | 152 | 13 | GO:0005925 |
| GeneOntologyCellularComponent | cell-substrate junction | FLNA FLNB FLNC NOX4 ACTN4 LASP1 YES1 GSN PTPN12 AFAP1 PLEC PHLDB2 CAP1 | 2.22e-05 | 443 | 152 | 13 | GO:0030055 |
| GeneOntologyCellularComponent | actin cytoskeleton | FLNA FLNB FLNC ARHGAP32 SHROOM3 NOX4 ACTN4 LASP1 YES1 GSN PTPN12 AFAP1 LRRC7 CAP1 | 8.28e-05 | 576 | 152 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | anchoring collagen complex | 1.57e-04 | 3 | 152 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.87e-04 | 114 | 152 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 3.65e-04 | 129 | 152 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | cell-cell junction | ILDR2 FLNA SHROOM3 DSG2 ACTN4 GSN KRIT1 FAT2 PIK3R1 PRKCA DLG3 LRRC7 PARD3 | 3.92e-04 | 591 | 152 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 5.91e-04 | 93 | 152 | 5 | GO:0030864 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 1.20e-03 | 29 | 152 | 3 | GO:0097038 | |
| MousePheno | dehydration | 1.59e-05 | 83 | 136 | 7 | MP:0001429 | |
| Domain | ACTININ_2 | 9.36e-07 | 23 | 150 | 5 | PS00020 | |
| Domain | ACTININ_1 | 9.36e-07 | 23 | 150 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.36e-07 | 23 | 150 | 5 | IPR001589 | |
| Domain | IG_FLMN | 5.85e-05 | 10 | 150 | 3 | SM00557 | |
| Domain | Filamin | 7.99e-05 | 11 | 150 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 7.99e-05 | 11 | 150 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 7.99e-05 | 11 | 150 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 7.99e-05 | 11 | 150 | 3 | IPR017868 | |
| Domain | - | EPHB6 GP6 ILDR2 FLNA FLNB FLNC COL7A1 COL12A1 PILRB PILRA MDGA2 TRIM67 NTM ROS1 IGSF1 MYBPC1 | 8.80e-05 | 663 | 150 | 16 | 2.60.40.10 |
| Domain | CH | 1.75e-04 | 65 | 150 | 5 | SM00033 | |
| Domain | Ig-like_fold | EPHB6 GP6 ILDR2 FLNA FLNB FLNC COL7A1 COL12A1 PILRB PILRA MDGA2 TRIM67 NTM ROS1 IGSF1 MYBPC1 | 1.81e-04 | 706 | 150 | 16 | IPR013783 |
| Domain | CH | 2.49e-04 | 70 | 150 | 5 | PF00307 | |
| Domain | FKBP_PPIASE | 2.63e-04 | 16 | 150 | 3 | PS50059 | |
| Domain | FKBP_C | 2.63e-04 | 16 | 150 | 3 | PF00254 | |
| Domain | - | 2.66e-04 | 71 | 150 | 5 | 1.10.418.10 | |
| Domain | FN3_dom | 2.91e-04 | 209 | 150 | 8 | IPR003961 | |
| Domain | CH | 3.03e-04 | 73 | 150 | 5 | PS50021 | |
| Domain | PPIase_FKBP | 3.18e-04 | 17 | 150 | 3 | IPR023566 | |
| Domain | CH-domain | 3.43e-04 | 75 | 150 | 5 | IPR001715 | |
| Domain | PPIase_FKBP_dom | 5.24e-04 | 20 | 150 | 3 | IPR001179 | |
| Domain | FN3 | 7.47e-04 | 185 | 150 | 7 | SM00060 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA FLNB FLNC HSPH1 SLU7 PSMD1 ACTN4 ACTL6A LASP1 MCCC2 DHX33 RRM1 PRPF8 NT5DC1 PTPN12 NAMPT OXCT1 NF1 PLAA TPP1 PRKCA TAF2 PLEC PARD3 QARS1 MGA ZMYM3 GOLGA4 PHLDB2 CAP1 | 1.89e-13 | 1353 | 152 | 30 | 29467282 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FKBP10 FLNA FLNB FLNC DSG2 HSPH1 ACTN4 GPRC5C ACTL6A LASP1 RRM1 PRPF8 YES1 NDUFS2 GSN PTPN12 NAMPT OXCT1 PLAA AARS2 NTM AGL PRKCA HSD17B4 QARS1 PCCA NNT PHLDB2 | 8.82e-12 | 1367 | 152 | 28 | 32687490 |
| Pubmed | FLNA FLNB ARHGAP32 ACADVL KCNAB2 PSMD1 ACTN4 LASP1 MCCC2 LRP1B NDUFS2 TAB3 NAMPT OXCT1 NF1 PLAA SLITRK5 PRKCA DLG3 LRRC7 PLEC PCCA CAP1 | 1.04e-09 | 1139 | 152 | 23 | 36417873 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ARHGAP32 SHROOM3 DSG2 BACH2 HSPH1 ACTN4 LASP1 MCCC2 CFI YES1 LRP1B TAB3 LENG8 OSBPL3 PRKCA TAF2 PLEC HSD17B4 MGA PCCA | 1.15e-09 | 853 | 152 | 20 | 28718761 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNA FLNB FLNC ACADVL HSPH1 PSMD1 ACTN4 MCCC2 COG3 PRPF8 GSN NBAS NAMPT PLEC QARS1 PCCA NNT CAP1 ALG13 | 2.89e-09 | 807 | 152 | 19 | 30575818 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | LGMN FLNA FLNB FLNC HSPH1 KCNAB2 PSMD1 ACTN4 PRPF8 JUN PLEC NNT CAP1 | 4.41e-09 | 344 | 152 | 13 | 30333137 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA FLNB CACNA2D1 FLNC ACADVL DSG2 PSMD1 ACTN4 LASP1 PRPF8 YES1 GSN NF1 AARS2 PRKCA PLEC HSD17B4 QARS1 MGA NNT PHLDB2 | 4.55e-09 | 1024 | 152 | 21 | 24711643 |
| Pubmed | 8.96e-09 | 94 | 152 | 8 | 35122331 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | MPST ACADVL ACTN4 LASP1 MCCC2 PRPF8 NDUFS2 GSN NAMPT RBM12 PLAA AARS2 AGL HSD17B4 QARS1 NNT | 1.17e-08 | 607 | 152 | 16 | 39147351 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MPST GP6 LGMN FLNA FLNB CACNA2D1 SPINK1 ACTN4 GPRC5C CPE CFI GSN FREM2 NAMPT TPP1 LTBP2 TMC5 PZP CAP1 MASP2 | 5.02e-08 | 1070 | 152 | 20 | 23533145 |
| Pubmed | 7.56e-08 | 49 | 152 | 6 | 21362503 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 12393796 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 11153914 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 11252955 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 12704190 | ||
| Pubmed | FLNA HSPH1 KCNAB2 SLU7 PTPN22 ACTN4 ZNF217 ACTL6A LASP1 RRM1 GSN LENG8 JUN RBM12 QSER1 HSD17B4 COPS5 FKBP5 ZMYM3 CAP1 | 8.21e-08 | 1103 | 152 | 20 | 34189442 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 9.50e-08 | 235 | 152 | 10 | 28378594 | |
| Pubmed | FLNA FLNC ARHGAP32 PSMD1 ACTN4 LENG8 JUN BRAF PIK3R1 WASH2P PLEC MGA COPS5 | 2.48e-07 | 486 | 152 | 13 | 20936779 | |
| Pubmed | SOX6 ARHGAP32 EYA4 HSPH1 SLU7 PSMD1 ZNF217 ACTL6A LASP1 MCCC2 DCAF5 ZFPM2 TAB3 LENG8 JUN RBM12 TAF2 QSER1 QARS1 MGA PCCA ZMYM3 | 2.95e-07 | 1429 | 152 | 22 | 35140242 | |
| Pubmed | LGMN NRDE2 FLNA FLNB HSPH1 SLU7 PSMD1 ACTN4 NT5DC1 DCAF5 PLAA BRAF OSBPL3 PIK3R1 QSER1 PLEC SEC63 PARD3 MGA | 2.98e-07 | 1084 | 152 | 19 | 11544199 | |
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 11739414 | ||
| Pubmed | Structural interaction and functional regulation of polycystin-2 by filamin. | 3.26e-07 | 4 | 152 | 3 | 22802962 | |
| Pubmed | 4.21e-07 | 65 | 152 | 6 | 34645483 | ||
| Pubmed | ARHGAP32 HSPH1 KCNAB2 ACTN4 CPE YES1 NDUFS2 OXCT1 NF1 DLG3 LRRC7 PARD3 | 4.69e-07 | 430 | 152 | 12 | 32581705 | |
| Pubmed | 5.37e-07 | 159 | 152 | 8 | 34537242 | ||
| Pubmed | 5.62e-07 | 285 | 152 | 10 | 21423176 | ||
| Pubmed | 7.39e-07 | 226 | 152 | 9 | 31452512 | ||
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 12006559 | ||
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 17360453 | ||
| Pubmed | Characterization of the murine orthologue of a novel human subtelomeric multigene family. | 8.13e-07 | 5 | 152 | 3 | 11701968 | |
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 19366992 | ||
| Pubmed | FLNA FLNB DSG2 HSPH1 PSMD1 ACTN4 RRM1 PRPF8 NAMPT AARS2 PLEC HSD17B4 QARS1 CAP1 | 9.05e-07 | 638 | 152 | 14 | 33239621 | |
| Pubmed | SOX6 EPHB6 FLNB HSPH1 ZBTB4 KCNAB2 PSMD1 ACTN4 ZFC3H1 PRPF8 LRP1B DCAF5 KRIT1 PIK3R1 TPP1 RORB PLEC HSD17B4 QARS1 COPS5 | 9.11e-07 | 1285 | 152 | 20 | 35914814 | |
| Pubmed | HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress. | 9.85e-07 | 41 | 152 | 5 | 24614889 | |
| Pubmed | CACNA2D1 ARHGAP32 SHROOM3 KCNAB2 GSN NF1 TRIM67 DNAJA4 OSBPL3 PRKCA DLG3 LRRC7 QSER1 PARD3 MGA GOLGA4 PHLDB2 | 1.19e-06 | 963 | 152 | 17 | 28671696 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.31e-06 | 179 | 152 | 8 | 36261009 | |
| Pubmed | FLNA FLNB CACNA2D1 HSPH1 PSMD1 ACTL6A COG3 RRM1 PRPF8 YES1 NDUFS2 GSN NBAS NAMPT AFAP1 OXCT1 AARS2 PRKCA SEC63 QARS1 FKBP5 | 1.34e-06 | 1440 | 152 | 21 | 30833792 | |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 1.49e-06 | 182 | 152 | 8 | 30711629 | |
| Pubmed | Human subtelomeric WASH genes encode a new subclass of the WASP family. | 1.62e-06 | 6 | 152 | 3 | 18159949 | |
| Pubmed | FLNA FLNB FLNC SHROOM3 HSPH1 ACTN4 LASP1 MCCC2 GSN PLEC QARS1 PHLDB2 | 1.76e-06 | 488 | 152 | 12 | 31324722 | |
| Pubmed | 1.94e-06 | 327 | 152 | 10 | 31409639 | ||
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 1.94e-06 | 327 | 152 | 10 | 15592455 | |
| Pubmed | 2.13e-06 | 191 | 152 | 8 | 33762435 | ||
| Pubmed | COL12A1 ACADVL DSG2 WASHC1 PSMD1 ACTL6A MCCC2 CR2 DCAF5 AARS2 TRPM3 OSBPL3 TAF2 MGA | 2.22e-06 | 689 | 152 | 14 | 36543142 | |
| Pubmed | FKBP10 SHROOM3 ACADVL DSG2 HSPH1 SLU7 MCCC2 ZFC3H1 RRM1 PRPF8 YES1 NDUFS2 DCAF5 NBAS TIMM21 DNAJA4 PIK3R1 SEC63 PARD3 FKBP5 GOLGA4 | 2.22e-06 | 1487 | 152 | 21 | 33957083 | |
| Pubmed | 2.35e-06 | 334 | 152 | 10 | 30425250 | ||
| Pubmed | FLNA PDHA2 HSPH1 PSMD1 ACTN4 ZNF217 ACTL6A LASP1 MCCC2 PRPF8 YES1 BRAF PIK3R1 PARD3 QARS1 MGA FKBP5 PHLDB2 CAP1 | 2.38e-06 | 1247 | 152 | 19 | 27684187 | |
| Pubmed | FLNA FLNB ACADVL HSPH1 PSMD1 ACTN4 LASP1 PRPF8 ZFPM2 GSN NF1 PLEC QARS1 GOLGA4 CAP1 | 2.66e-06 | 803 | 152 | 15 | 36517590 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | FKBP10 ACADVL HSPH1 PSMD1 MCCC2 RRM1 PRPF8 NDUFS2 AGL SEC63 NNT | 2.76e-06 | 422 | 152 | 11 | 27342126 |
| Pubmed | 2.83e-06 | 7 | 152 | 3 | 23525008 | ||
| Pubmed | 2.83e-06 | 7 | 152 | 3 | 16076904 | ||
| Pubmed | FLNB ARHGAP32 DSG2 HSPH1 PSMD1 RRM1 NDUFS2 SLITRK5 LRRC7 SEC63 PARD3 QARS1 GOLGA4 CAP1 | 3.04e-06 | 708 | 152 | 14 | 39231216 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | NRDE2 FLNA FLNC HSPH1 LASP1 ZFC3H1 PRPF8 GSN MEX3A TAF2 PLEC QARS1 MGA NNT | 3.92e-06 | 724 | 152 | 14 | 36232890 |
| Pubmed | Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development. | 3.97e-06 | 54 | 152 | 5 | 31792442 | |
| Pubmed | MPST FKBP10 FLNA FLNB CACNA2D1 COL12A1 DSG2 HSPH1 ACTN4 MCCC2 RRM1 PRPF8 YES1 PTPN12 AFAP1 DNAJA4 TPP1 SEC63 QARS1 | 4.20e-06 | 1297 | 152 | 19 | 33545068 | |
| Pubmed | Differentially regulated and evolved genes in the fully sequenced Xq/Yq pseudoautosomal region. | 4.51e-06 | 8 | 152 | 3 | 10655549 | |
| Pubmed | MEKK4 signaling regulates filamin expression and neuronal migration. | 4.51e-06 | 8 | 152 | 3 | 17145501 | |
| Pubmed | 4.55e-06 | 360 | 152 | 10 | 33111431 | ||
| Pubmed | CDK12 PSMD1 ACTL6A COG3 RRM1 NAMPT AARS2 TRNAU1AP TAF2 QARS1 COPS5 | 5.20e-06 | 451 | 152 | 11 | 30033366 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | MPST FKBP10 LGMN FLNA FLNB FLNC ACADVL PSMD1 ACTN4 MCCC2 EPB41L4A PRPF8 NDUFS2 DCAF5 RBM12 AARS2 PLEC SEC63 HSD17B4 PCCA | 5.69e-06 | 1451 | 152 | 20 | 30550785 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FKBP10 FLNA FLNB FLNC HSPH1 PSMD1 ACTN4 COG3 RRM1 PTPN12 NAMPT RBM12 OXCT1 PLAA AGL PLEC QARS1 COPS5 FKBP5 CAP1 | 5.92e-06 | 1455 | 152 | 20 | 22863883 |
| Pubmed | MPST FKBP10 CACNA2D1 ACADVL PDHA2 ACTN4 MCCC2 NDUFS2 OXCT1 AARS2 TPP1 LTBP2 HSD17B4 NNT CAP1 | 5.98e-06 | 859 | 152 | 15 | 31536960 | |
| Pubmed | FLNA FLNB CDK12 HSPH1 PSMD1 RRM1 PRPF8 NDUFS2 DCAF5 JUN PLAA DNAJA4 SEC63 QARS1 FKBP5 MASP2 | 5.98e-06 | 971 | 152 | 16 | 33306668 | |
| Pubmed | 6.74e-06 | 9 | 152 | 3 | 11807098 | ||
| Pubmed | ACADVL PDHA2 MCCC2 NDUFS2 OXCT1 AARS2 TIMM21 HSD17B4 PCCA NNT | 7.65e-06 | 382 | 152 | 10 | 29222160 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | FLNA FLNB FLNC CDK12 HSPH1 DAB1 ACTN4 LASP1 GSN OXCT1 PLEC GOLGA4 | 7.66e-06 | 564 | 152 | 12 | 21565611 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLNA CDK12 PSMD1 ZNF217 JUN NF1 BRAF PLEC PARD3 KAT6B FKBP5 ZMYM3 GOLGA4 PHLDB2 | 8.36e-06 | 774 | 152 | 14 | 15302935 |
| Pubmed | NRDE2 FLNA DSG2 CDK12 HSPH1 DAB1 LASP1 PRPF8 LENG8 NAMPT BRAF TRNAU1AP OSBPL3 AGL ROS1 PLEC SEC63 PARD3 QARS1 | 9.21e-06 | 1371 | 152 | 19 | 36244648 | |
| Pubmed | 9.60e-06 | 10 | 152 | 3 | 36357400 | ||
| Pubmed | FLNA FLNB FLNC HSPH1 PSMD1 TRNAU1AP DNAJA4 AGL PLEC QARS1 CAP1 | 1.22e-05 | 494 | 152 | 11 | 26831064 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FKBP10 FLNA FLNB FLNC CDK12 HSPH1 PSMD1 ACTN4 ACTL6A PRPF8 GSN TPP1 AGL PLEC QARS1 FKBP5 CAP1 | 1.23e-05 | 1149 | 152 | 17 | 35446349 |
| Pubmed | 1.32e-05 | 11 | 152 | 3 | 36579465 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNA FLNB ACADVL HSPH1 PSMD1 ACTN4 LASP1 MCCC2 RRM1 PRPF8 NDUFS2 GSN NAMPT DNAJA4 AGL PLEC HSD17B4 QARS1 GOLGA4 | 1.43e-05 | 1415 | 152 | 19 | 28515276 |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.45e-05 | 248 | 152 | 8 | 24006456 | |
| Pubmed | FLNA CACNA2D1 CPAMD8 COL12A1 DSG2 NOX4 ACTN4 ST3GAL4 REN RRM1 CFI ASB13 NF1 TPP1 PLEC CAP1 MYBPC1 ALG13 | 1.52e-05 | 1293 | 152 | 18 | 15342556 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNA FLNB DSG2 HSPH1 PSMD1 ACTN4 ACTL6A MCCC2 PRPF8 NDUFS2 NAMPT NF1 SEC63 HSD17B4 QARS1 NNT GOLGA4 CAP1 MYBPC1 | 1.58e-05 | 1425 | 152 | 19 | 30948266 |
| Pubmed | ILDR2 FLNA FLNB CACNA2D1 FLNC ARHGAP32 HSPH1 KCNAB2 ACTN4 NDUFS2 GSN AFAP1 NF1 NTM PRKCA DLG3 LRRC7 PLEC CAP1 | 1.67e-05 | 1431 | 152 | 19 | 37142655 | |
| Pubmed | 1.68e-05 | 332 | 152 | 9 | 37433992 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 12376540 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 17635842 | ||
| Pubmed | WASH and the Arp2/3 complex regulate endosome shape and trafficking. | 1.90e-05 | 2 | 152 | 2 | 20175130 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 30348826 | ||
| Pubmed | A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha. | 1.90e-05 | 2 | 152 | 2 | 9694715 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 27925688 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 7689010 | ||
| Pubmed | PILRα and PILRβ have a siglec fold and provide the basis of binding to sialic acid. | 1.90e-05 | 2 | 152 | 2 | 24843130 | |
| Pubmed | KRIT1 loss of function causes a ROS-dependent upregulation of c-Jun. | 1.90e-05 | 2 | 152 | 2 | 24291398 | |
| Pubmed | Filamin depletion blocks endoplasmic spreading and destabilizes force-bearing adhesions. | 1.90e-05 | 2 | 152 | 2 | 21325628 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 23171796 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 10679933 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 37272080 | ||
| Pubmed | Possible role of c-Jun in transcription of the mouse renin gene. | 1.90e-05 | 2 | 152 | 2 | 9690204 | |
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 1.90e-05 | 2 | 152 | 2 | 24469451 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 20686018 | ||
| Pubmed | Somatic mutations and germline sequence variants in patients with familial colorectal cancer. | 1.90e-05 | 2 | 152 | 2 | 21351276 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 27401113 | ||
| Pubmed | Protein kinase Cα regulates the nucleocytoplasmic shuttling of KRIT1. | 1.90e-05 | 2 | 152 | 2 | 33443102 | |
| Pubmed | The limits of promiscuity: isoform-specific dimerization of filamins. | 1.90e-05 | 2 | 152 | 2 | 12525170 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 11336782 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 16920989 | ||
| Interaction | PER2 interactions | 2.17e-08 | 153 | 151 | 11 | int:PER2 | |
| Interaction | HSPB1 interactions | FLNB EYA4 HSPH1 PSMD1 PTPN22 ACTN4 LASP1 MCCC2 PRPF8 YES1 NBAS PTPN12 NAMPT OXCT1 TRIM67 BRAF TIMM21 PRKCA NNT COPS5 | 3.51e-07 | 708 | 151 | 20 | int:HSPB1 |
| Interaction | ITGB3 interactions | 6.30e-07 | 170 | 151 | 10 | int:ITGB3 | |
| Interaction | PRNP interactions | FLNA FLNC COL12A1 ACADVL DSG2 WASHC1 PSMD1 ACTN4 CPE ACTL6A LASP1 MCCC2 CR2 DCAF5 TRIM67 AARS2 TRPM3 OSBPL3 NTM TPP1 AGL C11orf68 DLG3 TAF2 MGA | 1.63e-06 | 1158 | 151 | 25 | int:PRNP |
| Interaction | LIMA1 interactions | FLNA FLNB DSG2 HSPH1 PSMD1 ACTN4 PRPF8 YES1 GSN AFAP1 NF1 TRIM67 PLEC PHLDB2 | 4.43e-06 | 429 | 151 | 14 | int:LIMA1 |
| Interaction | CCDC8 interactions | FLNA FLNB CACNA2D1 ACADVL DSG2 PSMD1 ACTN4 LASP1 PRPF8 NF1 AARS2 PRKCA PLEC HSD17B4 QARS1 NNT PHLDB2 | 8.87e-06 | 656 | 151 | 17 | int:CCDC8 |
| Interaction | PTPN12 interactions | 1.38e-05 | 145 | 151 | 8 | int:PTPN12 | |
| Interaction | FLNB interactions | FLNA FLNB FLNC HSPH1 KCNAB2 PTPN12 MEX3A TRIM67 QARS1 FKBP5 CAP1 | 1.90e-05 | 304 | 151 | 11 | int:FLNB |
| Interaction | FBXO43 interactions | 1.95e-05 | 74 | 151 | 6 | int:FBXO43 | |
| Interaction | HSPA6 interactions | FLNA FLNB PRPF8 PTPN12 TRIM67 BRAF DNAJA4 PARD3 QARS1 COPS5 CAP1 | 2.34e-05 | 311 | 151 | 11 | int:HSPA6 |
| Interaction | FLNA interactions | FLNA FLNB FLNC DSG2 ACTN4 RRM1 PRPF8 GSN PTPN12 AFAP1 MEX3A TRIM67 PRKCA PLEC QARS1 PHLDB2 | 2.98e-05 | 648 | 151 | 16 | int:FLNA |
| Interaction | ACTG1 interactions | FLNA FLNB ARHGAP32 SHROOM3 WASHC1 ACTL6A PRPF8 GSN PTPN12 TRIM67 PRKCA PLEC FKBP5 CAP1 | 3.80e-05 | 520 | 151 | 14 | int:ACTG1 |
| Interaction | RASA1 interactions | 3.82e-05 | 167 | 151 | 8 | int:RASA1 | |
| Interaction | TPM3 interactions | HSPH1 WASHC1 PSMD1 ACTN4 ZFC3H1 PRPF8 JUN WASH3P TRIM67 FKBP5 GOLGA4 CAP1 | 3.90e-05 | 390 | 151 | 12 | int:TPM3 |
| Interaction | LEO1 interactions | 4.82e-05 | 278 | 151 | 10 | int:LEO1 | |
| Interaction | ITGB1 interactions | FLNA FLNB HSPH1 PSMD1 ACTN4 PRPF8 JUN TRIM67 PIK3R1 PRKCA PLEC SEC63 | 4.98e-05 | 400 | 151 | 12 | int:ITGB1 |
| Interaction | CCDC88A interactions | 5.32e-05 | 226 | 151 | 9 | int:CCDC88A | |
| Interaction | NPHP1 interactions | 5.64e-05 | 130 | 151 | 7 | int:NPHP1 | |
| Interaction | ITGB2 interactions | 6.22e-05 | 132 | 151 | 7 | int:ITGB2 | |
| Interaction | BRSK2 interactions | 6.32e-05 | 91 | 151 | 6 | int:BRSK2 | |
| Interaction | EMC2 interactions | FKBP10 ACADVL HSPH1 PSMD1 MCCC2 RRM1 NDUFS2 TRIM67 AGL SEC63 HSD17B4 NNT | 6.45e-05 | 411 | 151 | 12 | int:EMC2 |
| Interaction | PTEN interactions | FKBP10 FLNA FLNB SHROOM3 ACADVL HSPH1 KCNAB2 ACTL6A MCCC2 PRPF8 YES1 NF1 BRAF PIK3R1 TPP1 PLEC PCCA NNT FKBP5 | 6.83e-05 | 929 | 151 | 19 | int:PTEN |
| Interaction | HDAC6 interactions | FLNA FLNB DSG2 HSPH1 PSMD1 ACTN4 ZNF217 LASP1 PLA2G4E PRPF8 YES1 GSN BBS10 TRIM67 PLAA PRKCA PLEC QARS1 ZMYM3 | 6.83e-05 | 929 | 151 | 19 | int:HDAC6 |
| Interaction | AGR2 interactions | FLNA FLNB FLNC ACADVL HSPH1 PSMD1 ACTN4 MCCC2 COG3 PRPF8 GSN NBAS NAMPT PLEC QARS1 PCCA NNT CAP1 ALG13 | 7.33e-05 | 934 | 151 | 19 | int:AGR2 |
| Interaction | SACS interactions | 7.99e-05 | 59 | 151 | 5 | int:SACS | |
| Interaction | GSK3B interactions | FLNA DSG2 HSPH1 PSMD1 ACTN4 RRM1 GSN JUN PTPN12 AFAP1 TRIM67 PRKCA PLEC HSD17B4 QARS1 COPS5 FKBP5 CAP1 | 9.03e-05 | 868 | 151 | 18 | int:GSK3B |
| Interaction | NCF1 interactions | 9.56e-05 | 98 | 151 | 6 | int:NCF1 | |
| Interaction | EGLN3 interactions | LGMN ARHGAP32 EYA4 DSG2 CDK12 HSPH1 PSMD1 MCCC2 RRM1 NDUFS2 ZFPM2 LENG8 JUN NAMPT MEX3A PLAA TIMM21 OSBPL3 TPP1 HSD17B4 PARD3 MGA ALG13 | 9.85e-05 | 1296 | 151 | 23 | int:EGLN3 |
| Interaction | MYO18A interactions | 9.86e-05 | 303 | 151 | 10 | int:MYO18A | |
| Interaction | ARRB1 interactions | 1.01e-04 | 304 | 151 | 10 | int:ARRB1 | |
| Interaction | SYNPO interactions | 1.02e-04 | 192 | 151 | 8 | int:SYNPO | |
| Interaction | PHLDB2 interactions | 1.03e-04 | 143 | 151 | 7 | int:PHLDB2 | |
| Interaction | ACTA1 interactions | WASHC1 PTPN22 ACTN4 LASP1 GSN AFAP1 TRIM67 PIK3R1 PRKCA PLEC CAP1 | 1.14e-04 | 371 | 151 | 11 | int:ACTA1 |
| Interaction | SLC6A4 interactions | ARHGAP32 HSPH1 KCNAB2 ACTN4 CPE YES1 NDUFS2 OXCT1 NF1 DLG3 LRRC7 PARD3 | 1.15e-04 | 437 | 151 | 12 | int:SLC6A4 |
| Interaction | RPS6KA2 interactions | 1.18e-04 | 196 | 151 | 8 | int:RPS6KA2 | |
| Interaction | UBA2 interactions | 1.26e-04 | 253 | 151 | 9 | int:UBA2 | |
| Interaction | GSTM3 interactions | 1.28e-04 | 148 | 151 | 7 | int:GSTM3 | |
| Interaction | WDR6 interactions | EPHB6 EPB41L4A JUN MEX3A TRIM67 BRAF PIK3R1 PARD3 COPS5 FKBP5 | 1.32e-04 | 314 | 151 | 10 | int:WDR6 |
| Interaction | DCAF15 interactions | 1.34e-04 | 255 | 151 | 9 | int:DCAF15 | |
| Interaction | ANK3 interactions | 1.40e-04 | 201 | 151 | 8 | int:ANK3 | |
| Interaction | PROK2 interactions | 1.41e-04 | 14 | 151 | 3 | int:PROK2 | |
| Interaction | IQGAP1 interactions | FLNA FLNB DSG2 PSMD1 ACTN4 PRPF8 GSN AFAP1 TRIM67 BRAF PLEC QARS1 GOLGA4 CAP1 | 1.48e-04 | 591 | 151 | 14 | int:IQGAP1 |
| Interaction | VBP1 interactions | 1.50e-04 | 203 | 151 | 8 | int:VBP1 | |
| Interaction | EFS interactions | 1.65e-04 | 37 | 151 | 4 | int:EFS | |
| Interaction | DET1 interactions | 1.70e-04 | 155 | 151 | 7 | int:DET1 | |
| Interaction | NXF1 interactions | COL7A1 ARHGAP32 BACH2 SLU7 PSMD1 ACTL6A LASP1 PRPF8 NDUFS2 KRIT1 ASB13 JUN NAMPT AFAP1 RBM12 NF1 TRIM67 OSBPL3 AGL PRKCA QARS1 COPS5 ZMYM3 | 1.71e-04 | 1345 | 151 | 23 | int:NXF1 |
| Interaction | FGD5 interactions | 1.71e-04 | 207 | 151 | 8 | int:FGD5 | |
| Interaction | APC interactions | FLNA ACADVL SLU7 PSMD1 EPB41L4A JUN TRIM67 PRKCA DLG3 PARD3 COPS5 | 1.73e-04 | 389 | 151 | 11 | int:APC |
| Interaction | PDLIM7 interactions | 1.73e-04 | 264 | 151 | 9 | int:PDLIM7 | |
| Interaction | MYH9 interactions | FLNA FLNB SHROOM3 DSG2 HSPH1 PSMD1 ACTN4 YES1 GSN AFAP1 MEX3A TRIM67 PLEC NNT COPS5 GOLGA4 | 1.75e-04 | 754 | 151 | 16 | int:MYH9 |
| Interaction | RBM12 interactions | 1.81e-04 | 110 | 151 | 6 | int:RBM12 | |
| Interaction | CNTNAP2 interactions | 1.91e-04 | 158 | 151 | 7 | int:CNTNAP2 | |
| Interaction | CUL7 interactions | FLNA FLNB ARHGAP32 DSG2 FIGNL2 ACTN4 ZFC3H1 PRPF8 YES1 GSN TRIM67 TPP1 PLEC HSD17B4 QARS1 NNT PHLDB2 | 2.05e-04 | 845 | 151 | 17 | int:CUL7 |
| Interaction | TES interactions | 2.07e-04 | 332 | 151 | 10 | int:TES | |
| Interaction | AFDN interactions | EPHB6 ILDR2 ARHGAP32 SHROOM3 DSG2 PSMD1 YES1 TRIM67 PARD3 PHLDB2 | 2.12e-04 | 333 | 151 | 10 | int:AFDN |
| Interaction | TBCC interactions | 2.15e-04 | 16 | 151 | 3 | int:TBCC | |
| Interaction | MAT2A interactions | 2.44e-04 | 218 | 151 | 8 | int:MAT2A | |
| Interaction | PIPOX interactions | 2.60e-04 | 17 | 151 | 3 | int:PIPOX | |
| Interaction | CAMK2A interactions | 2.61e-04 | 279 | 151 | 9 | int:CAMK2A | |
| Interaction | DUSP4 interactions | 2.65e-04 | 118 | 151 | 6 | int:DUSP4 | |
| Interaction | FDPS interactions | 2.69e-04 | 167 | 151 | 7 | int:FDPS | |
| Interaction | PHF21A interactions | 2.69e-04 | 343 | 151 | 10 | int:PHF21A | |
| Interaction | PTK2B interactions | 2.77e-04 | 119 | 151 | 6 | int:PTK2B | |
| Interaction | JUP interactions | FLNA DSG2 HSPH1 EPB41L4A PRPF8 CFI TRIM67 BRAF PIK3R1 PLEC PARD3 COPS5 | 3.01e-04 | 485 | 151 | 12 | int:JUP |
| Interaction | EP300 interactions | FLNA SFRP1 EYA4 CDK12 PSMD1 ACTL6A LASP1 MCCC2 RRM1 PRPF8 ZFPM2 JUN NAMPT MEX3A OSBPL3 PIK3R1 PRKCA SEC63 TMC5 QARS1 COPS5 MASP2 ALG13 | 3.07e-04 | 1401 | 151 | 23 | int:EP300 |
| Interaction | CRKL interactions | 3.20e-04 | 227 | 151 | 8 | int:CRKL | |
| Interaction | USP14 interactions | FLNA FLNB FLNC DSG2 HSPH1 PSMD1 ACTN4 PRPF8 TRIM67 QARS1 COPS5 ZMYM3 | 3.24e-04 | 489 | 151 | 12 | int:USP14 |
| Interaction | PIAS1 interactions | 3.38e-04 | 353 | 151 | 10 | int:PIAS1 | |
| Interaction | ACTA2 interactions | 3.53e-04 | 355 | 151 | 10 | int:ACTA2 | |
| Interaction | ISG15 interactions | LGMN FLNA FLNB DSG2 PSMD1 ACTN4 PRPF8 GSN TRIM67 TAF2 PLEC QARS1 | 3.55e-04 | 494 | 151 | 12 | int:ISG15 |
| Interaction | MYBPC2 interactions | 3.55e-04 | 45 | 151 | 4 | int:MYBPC2 | |
| Interaction | MAP2K4 interactions | 3.58e-04 | 81 | 151 | 5 | int:MAP2K4 | |
| Interaction | ROR1 interactions | 3.77e-04 | 126 | 151 | 6 | int:ROR1 | |
| Interaction | VAT1 interactions | 3.93e-04 | 127 | 151 | 6 | int:VAT1 | |
| Interaction | MYOZ1 interactions | 4.20e-04 | 47 | 151 | 4 | int:MYOZ1 | |
| Interaction | BRCA1 interactions | FLNA FLNB FLNC PILRB HSPH1 PSMD1 NDUFS2 JUN AFAP1 NF1 PLAA TRNAU1AP DNAJA4 PIK3R1 TPP1 AGL SAGE1 PLEC QARS1 ZMYM3 CAP1 | 4.21e-04 | 1249 | 151 | 21 | int:BRCA1 |
| Interaction | MRPS11 interactions | 4.27e-04 | 237 | 151 | 8 | int:MRPS11 | |
| Interaction | ZNF224 interactions | 4.28e-04 | 20 | 151 | 3 | int:ZNF224 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 1.04e-04 | 16 | 106 | 3 | 14 | |
| GeneFamily | FKBP prolyl isomerases | 1.50e-04 | 18 | 106 | 3 | 910 | |
| GeneFamily | Fibronectin type III domain containing | 3.60e-04 | 160 | 106 | 6 | 555 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.19e-03 | 9 | 106 | 2 | 1234 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 1.39e-06 | 240 | 151 | 10 | M39236 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | MPST FLNA PILRB HSPH1 PSMD1 PTPN22 ZNF217 ACTL6A MCCC2 YES1 NBAS PTPN12 NAMPT OXCT1 PLAA AGL TAF2 SEC63 HSD17B4 PCCA NNT COPS5 FKBP5 | 5.41e-06 | 1399 | 151 | 23 | M535 |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | FLNA SHROOM3 ACADVL DSG2 ACTN4 ZNF217 LASP1 CFI NDUFS2 GSN JUN PTPN12 NAMPT AFAP1 PIK3R1 PRKCA TMC5 PARD3 NNT PHLDB2 CAP1 | 1.43e-05 | 1276 | 151 | 21 | M39173 |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN | 2.18e-05 | 200 | 151 | 8 | M8956 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 2.18e-05 | 200 | 151 | 8 | M9133 | |
| Coexpression | SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP | 5.79e-05 | 169 | 151 | 7 | M40877 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 6.24e-05 | 171 | 151 | 7 | M39234 | |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | FLNB NKX6-2 SPINK1 HSPH1 ACTN4 LASP1 GSN PLEC SEC63 GOLGA4 CAP1 | 7.37e-05 | 458 | 151 | 11 | M40010 |
| Coexpression | ALFANO_MYC_TARGETS | 7.70e-05 | 239 | 151 | 8 | M2477 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 7.75e-05 | 177 | 151 | 7 | M39245 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 9.49e-05 | 316 | 151 | 9 | M2293 | |
| Coexpression | DOANE_RESPONSE_TO_ANDROGEN_UP | 1.02e-04 | 185 | 151 | 7 | M7600 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 1.12e-04 | 323 | 151 | 9 | MM1066 | |
| Coexpression | LU_EZH2_TARGETS_DN | DSG2 PILRB MCCC2 TAB3 ASB13 SLC35A3 PTPN12 RBM12 HYLS1 SEC63 | 1.14e-04 | 400 | 151 | 10 | M2140 |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 1.14e-04 | 131 | 151 | 6 | M39232 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_POS_MATURE_B_CELL | LGMN FLNA KCNAB2 PTPN22 LASP1 MCCC2 CR2 NT5DC1 PTPN12 NAMPT AGL HSD17B4 FKBP5 | 1.33e-04 | 666 | 151 | 13 | M45778 |
| Coexpression | SENESE_HDAC3_TARGETS_UP | SFRP1 SLC25A37 TAB3 PTPN12 NAMPT NF1 PCNX4 TPP1 UBE2F LTBP2 PHLDB2 | 1.46e-04 | 495 | 151 | 11 | M8451 |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP | 1.61e-04 | 199 | 151 | 7 | M7420 | |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP | 1.66e-04 | 200 | 151 | 7 | M318 | |
| Coexpression | GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 1.66e-04 | 200 | 151 | 7 | M9675 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DN | 1.66e-04 | 200 | 151 | 7 | M8490 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP | 1.66e-04 | 200 | 151 | 7 | M8843 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN | 1.66e-04 | 200 | 151 | 7 | M6687 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP | 1.66e-04 | 200 | 151 | 7 | M6544 | |
| Coexpression | GSE20715_0H_VS_24H_OZONE_LUNG_DN | 1.66e-04 | 200 | 151 | 7 | M4367 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-09 | 195 | 153 | 10 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-08 | 192 | 153 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Biopsy_IPF-Epithelial-KRT5-/KRT17+|Biopsy_IPF / Sample group, Lineage and Cell type | 3.25e-08 | 200 | 153 | 9 | 2fc7a3b3aea711ad3d96fd9513f4b40533056d86 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-07 | 175 | 153 | 8 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-07 | 175 | 153 | 8 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.31e-07 | 182 | 153 | 8 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-07 | 184 | 153 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-07 | 184 | 153 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-07 | 184 | 153 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 2.95e-07 | 188 | 153 | 8 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 3.07e-07 | 189 | 153 | 8 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 3.07e-07 | 189 | 153 | 8 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.33e-07 | 191 | 153 | 8 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 3.61e-07 | 193 | 153 | 8 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.21e-07 | 197 | 153 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Control-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 4.21e-07 | 197 | 153 | 8 | 64cc5f61c88e9560b0f8f6f3151255dffb5c3d66 | |
| ToppCell | mLN-(0)_NK_cell-(00)_NK|mLN / shred on region, Cell_type, and subtype | 4.55e-07 | 199 | 153 | 8 | 59d8e4f57580c7273308c32e5308fc1d704b1f6d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.55e-07 | 199 | 153 | 8 | 103f657132e830a0e5efeb745afb4b77c208a1fa | |
| ToppCell | mLN-NK_cell-NK|mLN / Region, Cell class and subclass | 4.55e-07 | 199 | 153 | 8 | cc9836b8d18edabe8849a3e948b84d954ef68c48 | |
| ToppCell | mLN-NK_cell|mLN / Region, Cell class and subclass | 4.55e-07 | 199 | 153 | 8 | dcc1d9a3f6f0e64f111d18386bfe5b154e9d5bbe | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.55e-07 | 199 | 153 | 8 | ca970114b5aef4518ce580897a62ac88688b2671 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.55e-07 | 199 | 153 | 8 | 9846d6a31635fde759d55674631c11ab9270a603 | |
| ToppCell | mLN-(0)_NK_cell|mLN / shred on region, Cell_type, and subtype | 4.55e-07 | 199 | 153 | 8 | 05f5ae4c049f242131a7f59bcce4b18ed52f11be | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.72e-07 | 200 | 153 | 8 | c800f20adedf4ca736c740510889e92d8bf0ba44 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.72e-07 | 200 | 153 | 8 | bf50e30d5cafb71c567e89580f62084d2f894170 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.72e-07 | 200 | 153 | 8 | 5e5ad07679d5dd2ca80249bce9aaf4a95d42187b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.38e-07 | 151 | 153 | 7 | f4f7156b2c0cfc78fd1841e07c9915d97ced561f | |
| ToppCell | Control-Epithelial_airway-Club_cells-Airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-06 | 168 | 153 | 7 | ce87981f4da2779de952c2e5d2bbcdabb265e705 | |
| ToppCell | Control-Epithelial_airway-Club_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-06 | 168 | 153 | 7 | e85bc5398eb36b2b0773a8a7082e3ba740452165 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.07e-06 | 170 | 153 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.24e-06 | 172 | 153 | 7 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.33e-06 | 173 | 153 | 7 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.81e-06 | 178 | 153 | 7 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-06 | 178 | 153 | 7 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 3.02e-06 | 180 | 153 | 7 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 3.37e-06 | 183 | 153 | 7 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 3.37e-06 | 183 | 153 | 7 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.37e-06 | 183 | 153 | 7 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 3.37e-06 | 183 | 153 | 7 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | IPF-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 3.50e-06 | 184 | 153 | 7 | 7326a16d7d3ae41b8c9d2beaec7f977b374f3469 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.50e-06 | 184 | 153 | 7 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 3.50e-06 | 184 | 153 | 7 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 3.62e-06 | 185 | 153 | 7 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.62e-06 | 185 | 153 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 3.62e-06 | 185 | 153 | 7 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.62e-06 | 185 | 153 | 7 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-06 | 187 | 153 | 7 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.89e-06 | 187 | 153 | 7 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 4.17e-06 | 189 | 153 | 7 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.17e-06 | 189 | 153 | 7 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | MatrixFB-Fibroblast-C|MatrixFB / shred on cell class and cell subclass (v4) | 4.32e-06 | 190 | 153 | 7 | d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.47e-06 | 191 | 153 | 7 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-06 | 191 | 153 | 7 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.63e-06 | 192 | 153 | 7 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.63e-06 | 192 | 153 | 7 | 7ae3e1ca8bfc078c0e12a1595ecb0e343dab5d2f | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.79e-06 | 193 | 153 | 7 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-06 | 193 | 153 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.95e-06 | 194 | 153 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.95e-06 | 194 | 153 | 7 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 5.12e-06 | 195 | 153 | 7 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.12e-06 | 195 | 153 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.12e-06 | 195 | 153 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.12e-06 | 195 | 153 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 5.30e-06 | 196 | 153 | 7 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.30e-06 | 196 | 153 | 7 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | lymphoid-NK_cell|lymphoid / Lineage, cell class and subclass | 5.30e-06 | 196 | 153 | 7 | 0c7fb03ef782256f61624afc5c1bfaed9f1005fb | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-E|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.48e-06 | 197 | 153 | 7 | 9b1c1d72c5a8c90d71ae31e4c198d2276872eaa0 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.48e-06 | 197 | 153 | 7 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.48e-06 | 197 | 153 | 7 | 2744cc94883c5d0424677cf5093bbab622933e9b | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.48e-06 | 197 | 153 | 7 | 05e303fff86db31f7b742324c64980eb2b9cff9a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.48e-06 | 197 | 153 | 7 | 6b6440f1baad5680cf9e13ca3ab72a2c65523d59 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.48e-06 | 197 | 153 | 7 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.48e-06 | 197 | 153 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 5.65e-06 | 129 | 153 | 6 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.66e-06 | 198 | 153 | 7 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.66e-06 | 198 | 153 | 7 | 2e470249edc7cf85bed550795ff84cbef22895c0 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.66e-06 | 198 | 153 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.66e-06 | 198 | 153 | 7 | cfe2d52b19a1b4c2c2076fa1d5a69baf21a49623 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.85e-06 | 199 | 153 | 7 | 83383d9ae4f501754fd3da0215ce6f0e3c70562c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.05e-06 | 200 | 153 | 7 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 6.05e-06 | 200 | 153 | 7 | 553386523fd8f8f36617a0d81032224b7ddce442 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 6.05e-06 | 200 | 153 | 7 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.05e-06 | 200 | 153 | 7 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 6.05e-06 | 200 | 153 | 7 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.05e-06 | 200 | 153 | 7 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.05e-06 | 200 | 153 | 7 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 6.05e-06 | 200 | 153 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.05e-06 | 200 | 153 | 7 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | COVID-19_Mild-NK|COVID-19_Mild / Disease condition and Cell class | 6.05e-06 | 200 | 153 | 7 | b586b0f1127293c2f8529be16b24229359041da2 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 145 | 153 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.50e-05 | 153 | 153 | 6 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.55e-05 | 154 | 153 | 6 | 511923b27469ea20f8bd82a9ec27119a6e884644 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.61e-05 | 155 | 153 | 6 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.73e-05 | 157 | 153 | 6 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-05 | 158 | 153 | 6 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-05 | 161 | 153 | 6 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-05 | 162 | 153 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 165 | 153 | 6 | 1a114eacaab598f755a173a3fed842ba91f689dd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 165 | 153 | 6 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 165 | 153 | 6 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| Computational | Genes in the cancer module 202. | 5.76e-06 | 28 | 102 | 5 | MODULE_202 | |
| Computational | Actin cytoskeleton binding. | 8.23e-06 | 30 | 102 | 5 | MODULE_524 | |
| Computational | Genes in the cancer module 419. | 1.56e-05 | 34 | 102 | 5 | MODULE_419 | |
| Drug | losartan | CACNA2D1 COL7A1 COL12A1 NOX4 ACTN4 REN ACTL6A MMP24 JUN FAT2 TXNRD3 PRKCA MMP8 | 1.40e-06 | 378 | 150 | 13 | CID000003961 |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.21e-07 | 3 | 147 | 3 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.21e-07 | 3 | 147 | 3 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | EPHB6 FLNC COL7A1 CPAMD8 SFRP1 EYA4 CPE ZNF217 CSMD3 NAMPT NF1 BRAF DLG3 PZP | 1.19e-05 | 702 | 147 | 14 | C0009402 |
| Disease | melanoma | 3.63e-05 | 248 | 147 | 8 | C0025202 | |
| Disease | electrocardiography | SFRP1 PILRB DAB1 ZFC3H1 ZFPM2 PTPN12 TRPM3 PRKCA ROS1 PLEC KAT6B | 7.45e-05 | 530 | 147 | 11 | EFO_0004327 |
| Disease | Adenocarcinoma of large intestine | 1.22e-04 | 96 | 147 | 5 | C1319315 | |
| Disease | Melanocytic nevus | 1.47e-04 | 4 | 147 | 2 | C0027962 | |
| Disease | intrahepatic cholangiocarcinoma (is_implicated_in) | 1.47e-04 | 4 | 147 | 2 | DOID:4928 (is_implicated_in) | |
| Disease | Noonan Syndrome | 2.27e-04 | 24 | 147 | 3 | C0028326 | |
| Disease | Post-Traumatic Osteoporosis | 2.47e-04 | 61 | 147 | 4 | C0751406 | |
| Disease | Osteoporosis, Senile | 2.47e-04 | 61 | 147 | 4 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 2.47e-04 | 61 | 147 | 4 | C0001787 | |
| Disease | Prostatic Neoplasms | SPINK1 CDK12 GNMT LRP1B BRAF PIK3R1 TPP1 PARD3 MGA ZMYM3 GOLGA4 | 2.75e-04 | 616 | 147 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | SPINK1 CDK12 GNMT LRP1B BRAF PIK3R1 TPP1 PARD3 MGA ZMYM3 GOLGA4 | 2.75e-04 | 616 | 147 | 11 | C0376358 |
| Disease | Osteoporosis | 2.80e-04 | 63 | 147 | 4 | C0029456 | |
| Disease | neuroimaging measurement | MPST SHROOM3 SFRP1 DAB1 PSMD1 ACTN4 SLC25A37 STPG2 AFAP1 NF1 QSER1 PLEC TMC5 PARD3 PCCA | 3.02e-04 | 1069 | 147 | 15 | EFO_0004346 |
| Disease | creatinine measurement, glomerular filtration rate | 3.07e-04 | 117 | 147 | 5 | EFO_0004518, EFO_0005208 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 4.03e-04 | 29 | 147 | 3 | C0496920 | |
| Disease | Ovarian Carcinoma | 4.46e-04 | 30 | 147 | 3 | C0029925 | |
| Disease | Epileptic encephalopathy | 4.46e-04 | 30 | 147 | 3 | C0543888 | |
| Disease | hypertension (implicated_via_orthology) | 4.64e-04 | 128 | 147 | 5 | DOID:10763 (implicated_via_orthology) | |
| Disease | Colorectal Neoplasms | 4.96e-04 | 277 | 147 | 7 | C0009404 | |
| Disease | mean platelet volume | GP6 ARHGAP32 CDK12 ACTN4 ST3GAL4 ZNF217 DCAF5 SLC25A37 ZFPM2 AFAP1 TRPM3 DLG3 PLEC NNT | 5.99e-04 | 1020 | 147 | 14 | EFO_0004584 |
| Disease | aspartate aminotransferase measurement | SOX6 FLNB SHROOM3 EYA4 SPINK1 NOX4 ST3GAL4 LCT NF1 TRPM3 PIK3R1 PRKCA FKBP7 | 6.14e-04 | 904 | 147 | 13 | EFO_0004736 |
| Disease | endometrial carcinoma (is_marker_for) | 6.47e-04 | 34 | 147 | 3 | DOID:2871 (is_marker_for) | |
| Disease | eating behaviour, food addiction measurement | 6.77e-04 | 8 | 147 | 2 | EFO_0007829, EFO_0007830 | |
| Disease | Distal arthrogryposis | 8.67e-04 | 9 | 147 | 2 | cv:C0265213 | |
| Disease | low tension glaucoma | 8.67e-04 | 9 | 147 | 2 | EFO_1001022 | |
| Disease | Colon Carcinoma | 8.67e-04 | 9 | 147 | 2 | C0699790 | |
| Disease | Glaucoma | 8.67e-04 | 9 | 147 | 2 | C0017601 | |
| Disease | age at onset, Myopia | 9.50e-04 | 150 | 147 | 5 | EFO_0004847, HP_0000545 | |
| Disease | Glioma | 9.55e-04 | 87 | 147 | 4 | C0017638 | |
| Disease | descending aortic diameter | 9.97e-04 | 88 | 147 | 4 | EFO_0021788 | |
| Disease | cortical surface area measurement | ILDR2 FLNB CACNA2D1 CPAMD8 SHROOM3 SFRP1 DAB1 ACTN4 AGBL5 STPG2 AFAP1 PIK3R1 QSER1 PARD3 QARS1 PCCA | 1.13e-03 | 1345 | 147 | 16 | EFO_0010736 |
| Disease | Non-Small Cell Lung Carcinoma | 1.13e-03 | 156 | 147 | 5 | C0007131 | |
| Disease | high grade glioma (is_implicated_in) | 1.21e-03 | 42 | 147 | 3 | DOID:3070 (is_implicated_in) | |
| Disease | Malignant tumor of colon | 1.23e-03 | 159 | 147 | 5 | C0007102 | |
| Disease | Systemic lupus erythematosus | 1.32e-03 | 11 | 147 | 2 | cv:C0024141 | |
| Disease | cortical thickness | FLNB CPAMD8 SHROOM3 SFRP1 EYA4 COL12A1 DAB1 ACTN4 STPG2 PIK3R1 QSER1 PLEC PARD3 PCCA | 1.38e-03 | 1113 | 147 | 14 | EFO_0004840 |
| Disease | serine protease 27 measurement | 1.57e-03 | 12 | 147 | 2 | EFO_0008280 | |
| Disease | endometrial carcinoma (is_implicated_in) | 1.57e-03 | 12 | 147 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | disks large homolog 3 measurement | 1.57e-03 | 12 | 147 | 2 | EFO_0802472 | |
| Disease | dickkopf‐related protein 1 measurement | 1.57e-03 | 12 | 147 | 2 | EFO_0010620 | |
| Disease | pulse pressure measurement | SOX6 FLNB SHROOM3 NOX4 ACTN4 ST3GAL4 YES1 ZFPM2 GSN ASB13 PIEZO2 AFAP1 TRPM3 LTBP2 NNT GOLGA4 | 1.61e-03 | 1392 | 147 | 16 | EFO_0005763 |
| Disease | COVID-19, mortality | 1.65e-03 | 170 | 147 | 5 | EFO_0004352, MONDO_0100096 | |
| Disease | myopathy (implicated_via_orthology) | 1.78e-03 | 48 | 147 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | suntan | 1.78e-03 | 103 | 147 | 4 | EFO_0004279 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 1.85e-03 | 13 | 147 | 2 | C0369183 | |
| Disease | Genetic chronic primary adrenal insufficiency | 1.85e-03 | 13 | 147 | 2 | Orphanet_101960 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 1.85e-03 | 13 | 147 | 2 | C1261502 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.86e-03 | 447 | 147 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Abnormality of refraction | 2.07e-03 | 673 | 147 | 10 | HP_0000539 | |
| Disease | Glioblastoma Multiforme | 2.34e-03 | 111 | 147 | 4 | C1621958 | |
| Disease | reticulocyte measurement | SOX6 GP6 FLNA FLNB ACTN4 ZNF217 PRPF8 SLC25A37 DNAJA4 PIK3R1 RORB PAQR3 MYBPC1 | 2.40e-03 | 1053 | 147 | 13 | EFO_0010700 |
| Disease | Yu-Zhi constitution type | 2.48e-03 | 15 | 147 | 2 | EFO_0007638 | |
| Disease | RASopathy | 2.48e-03 | 15 | 147 | 2 | cv:C5555857 | |
| Disease | vitamin K-dependent protein C measurement | 2.48e-03 | 15 | 147 | 2 | EFO_0008318 | |
| Disease | immature platelet fraction | 2.58e-03 | 114 | 147 | 4 | EFO_0009187 | |
| Disease | basal cell carcinoma | 2.62e-03 | 189 | 147 | 5 | EFO_0004193 | |
| Disease | antisaccade response measurement | 2.77e-03 | 56 | 147 | 3 | EFO_0006874 | |
| Disease | pancreatitis | 2.83e-03 | 16 | 147 | 2 | EFO_0000278 | |
| Disease | response to acetylsalicylate | 2.83e-03 | 16 | 147 | 2 | GO_1903492 | |
| Disease | refractive error, age at onset, Myopia | 2.87e-03 | 193 | 147 | 5 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | serum albumin measurement | 2.96e-03 | 592 | 147 | 9 | EFO_0004535 | |
| Disease | immature platelet measurement | 3.01e-03 | 119 | 147 | 4 | EFO_0803541 | |
| Disease | blood nickel measurement | 3.11e-03 | 120 | 147 | 4 | EFO_0007583 | |
| Disease | Vitiligo | 3.19e-03 | 17 | 147 | 2 | C0042900 | |
| Disease | Hypogammaglobulinemia | 3.19e-03 | 17 | 147 | 2 | C0086438 | |
| Disease | oral motor function measurement | 3.19e-03 | 17 | 147 | 2 | EFO_0021793 | |
| Disease | cutaneous melanoma | 3.20e-03 | 121 | 147 | 4 | EFO_0000389 | |
| Disease | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | 3.37e-03 | 60 | 147 | 3 | EFO_0001365, EFO_0004683, EFO_1001492 | |
| Disease | PR interval | 3.47e-03 | 495 | 147 | 8 | EFO_0004462 | |
| Disease | adenosine monophosphate measurement | 3.58e-03 | 18 | 147 | 2 | EFO_0010454 | |
| Disease | Adrenocortical carcinoma | 3.58e-03 | 18 | 147 | 2 | C0206686 | |
| Disease | Disorder of organic acid metabolism | 3.58e-03 | 18 | 147 | 2 | cv:C1263739 | |
| Disease | autoimmune thyroid disease, Hashimoto's thyroiditis, Graves disease | 3.58e-03 | 18 | 147 | 2 | EFO_0003779, EFO_0004237, EFO_0006812 | |
| Disease | sexual dimorphism measurement | COL7A1 ZBTB4 TECTB NT5DC1 SLC25A37 MMP24 NF1 PIK3R1 C11orf68 LTBP2 PLEC MGA FKBP5 | 3.65e-03 | 1106 | 147 | 13 | EFO_0021796 |
| Disease | renal cell carcinoma (is_marker_for) | 3.91e-03 | 128 | 147 | 4 | DOID:4450 (is_marker_for) | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.99e-03 | 19 | 147 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Brugada syndrome | 3.99e-03 | 19 | 147 | 2 | MONDO_0015263 | |
| Disease | gut microbiome measurement, taxonomic microbiome measurement | 4.41e-03 | 66 | 147 | 3 | EFO_0007874, EFO_0007883 | |
| Disease | colorectal adenoma (is_marker_for) | 4.42e-03 | 20 | 147 | 2 | DOID:0050860 (is_marker_for) | |
| Disease | dilated cardiomyopathy | 4.42e-03 | 20 | 147 | 2 | EFO_0000407 | |
| Disease | testosterone measurement | SOX6 NRDE2 CACNA2D1 SHROOM3 ACADVL ZBTB4 REN CSMD3 SLC25A37 ZFPM2 NF1 TIMM21 PRKCA RORB | 4.70e-03 | 1275 | 147 | 14 | EFO_0004908 |
| Disease | Sarcoma | 4.86e-03 | 21 | 147 | 2 | C1261473 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APDTIPPKESGVAYY | 416 | Q8NDL9 | |
| KGYKPPDEGPSEYQT | 191 | Q92905 | |
| YACASPKTPIQAGGY | 746 | P15056 | |
| LKTDYTPFTGNYGQP | 381 | Q9BYV9 | |
| GKPEFPGVYTKVANY | 551 | P05156 | |
| GPTQSSAYGKLYRGP | 1461 | Q9NYV4 | |
| GKPPTYVTDNGYEDK | 321 | Q9NP73 | |
| GTVLSPNYPKNYSVG | 1771 | Q7Z407 | |
| EGYYEEAVPLSPGKA | 91 | Q8N556 | |
| SYGAKVNPPLYTASP | 106 | Q8WXK3 | |
| GKQGGPTYYIDTNAL | 61 | O96019 | |
| YQGPDAVPGALDYKS | 886 | O43707 | |
| YADSPSKAGAAPYVQ | 31 | Q01518 | |
| QYYDILGVKPSASPE | 6 | Q8WW22 | |
| FIYKNSGESYQAPDP | 446 | Q8TAM1 | |
| NSDSGAKKPTPPDYY | 246 | Q8N7E2 | |
| YPKDISNYGFPSSVQ | 361 | P22894 | |
| VEDSIYIAYGPNGKA | 456 | Q9NTZ6 | |
| NITVCGEYTYGKPVP | 246 | P20742 | |
| GEYTYGKPVPGLATV | 251 | P20742 | |
| PGYSQDAYKSVSTPL | 1236 | Q2KHR3 | |
| KGVYGPKAYIATQGP | 91 | Q9Y2R2 | |
| IPGSLKDNPYITDGY | 36 | Q6TCH7 | |
| YGSLDGKGAPQYPSA | 176 | Q8WYB5 | |
| PVTNVTAKGYEFNYP | 61 | A0A2R8YFM6 | |
| TYKYTGKGITEPPFG | 86 | Q14126 | |
| YAYGSAGSLPKIPSN | 111 | Q13451 | |
| PQAPQGAFISKEGYY | 521 | Q9Y5R2 | |
| SNSKTAGYYPNPPLV | 431 | Q5TFE4 | |
| TAGPTNYSNPVYAKL | 4551 | Q9NZR2 | |
| NDATVKGGAYYPVTV | 136 | Q9HCC0 | |
| PFYAGLSPAGKLVAY | 1451 | Q8IWI9 | |
| YPPYISEAKGTGVPV | 221 | Q9P121 | |
| IPSDYNLGNYGDKPS | 1231 | Q96NW7 | |
| NVYATTVGTPYKGGN | 2146 | Q13439 | |
| SESGPYGYSNPKILK | 21 | P05412 | |
| GQAYGPHTYTEPAKP | 201 | Q96PV6 | |
| TGADGYVPKYSPMNA | 2921 | Q5SZK8 | |
| KGADQLSPYYGIKPS | 976 | Q8WW38 | |
| YSDPQGVPYPEAKIG | 446 | Q92598 | |
| QQPVAQSYGGYKEPA | 176 | Q14847 | |
| QSYGGYKEPAAPVSI | 181 | Q14847 | |
| PKESDSPAGPARQYY | 251 | Q9HCN6 | |
| SPAGPARQYYTKGNL | 256 | Q9HCN6 | |
| AYGPGLVYGVANKTA | 1826 | O75369 | |
| QAAEPPLGYPIYSSK | 1151 | Q63HM2 | |
| GYVTYSIAGPKALPF | 491 | Q9NYQ8 | |
| ETVGQGPPPSKDYYQ | 11 | Q8NEA4 | |
| YKVDITYDGHPVPGS | 1036 | Q14315 | |
| GPYTVAVKYADQEVP | 1511 | Q14315 | |
| TKLTESSPYGPYTGQ | 851 | Q9H7Z3 | |
| APIKPTNTYIGEDNY | 601 | Q96JK2 | |
| GSSPSLPGVAYYNKL | 466 | P09848 | |
| PYFGLGAPDYSKIQI | 251 | O00522 | |
| TGCAPPGKNIYYKSD | 186 | Q14749 | |
| YAEDPYKSFGLPSIG | 401 | P05165 | |
| VINKTATGYGFAEPY | 671 | P27986 | |
| YGSKGIPDTSEPVSY | 1906 | A7KAX9 | |
| KIYDPVCGTDGNTYP | 41 | P00995 | |
| VLSGSPYYKQVTNGG | 276 | A2RRP1 | |
| PYYKQVTNGGDGVTA | 281 | A2RRP1 | |
| TAEPPKPAGVYYATA | 31 | Q6P4A8 | |
| VSGKYDSGIPPYSRA | 251 | Q13303 | |
| SIAPKNPYGPTNTAY | 821 | Q7Z553 | |
| TEGYQVPPGATYTAI | 386 | O75306 | |
| SRNYPKLYIDGPFGS | 401 | Q9NPH5 | |
| AKRPVSPYSGYNGQL | 351 | Q9NQ84 | |
| QGQVDIYGPKTPYAT | 806 | Q3MJ16 | |
| GSGPSYLYGVTQPKH | 26 | Q9UKJ1 | |
| LLTGSYAQKYGKDPP | 386 | O95677 | |
| VVIPPSFAYGKEGYA | 111 | Q9Y680 | |
| IPPFLAYGEKGYGTV | 231 | Q96AY3 | |
| AYGEKGYGTVIPPQA | 236 | Q96AY3 | |
| EGYAEPVDYQVPTGT | 166 | Q8N6C5 | |
| IQYDPYSKASVAPGK | 46 | Q96M11 | |
| PGTSIKYSCNPGYVL | 431 | P20023 | |
| VYDVPKSQPVSNGYS | 231 | O75553 | |
| PVGGATGYILSYKPV | 1496 | Q99715 | |
| TAPYFNKSGPGAYES | 776 | P54289 | |
| PGAYTVTIKYGGQPV | 1226 | P21333 | |
| YIQTDITGYKPAPGD | 471 | Q96JB2 | |
| GAIGQKLPPFSYAYT | 326 | P51659 | |
| AYVGKVELSYPDGSP | 361 | Q8IZJ3 | |
| KPVGAQYLPSYLSLG | 431 | Q8IZJ3 | |
| PGNYKLTASAPGYLA | 416 | P16870 | |
| SGKTTQIPQYLYEGG | 101 | Q9H6R0 | |
| YLGAVESKVSYPAPP | 346 | Q92796 | |
| PGGSYPAAAAAKVYS | 56 | Q14767 | |
| AYEKPPYPRGSVTAN | 601 | O00187 | |
| SGPVTGYKVQYTPLT | 256 | Q02388 | |
| NKVPVDPATYGQFYG | 456 | P06396 | |
| YAYEPAKAPVADGAS | 281 | A6NMB9 | |
| KELINTGPPYTLYFG | 81 | Q9HCS5 | |
| SYYRAGSKPFNPVLG | 596 | Q9H4L5 | |
| QPPSEGPSNYDSYKK | 1301 | Q8TEW0 | |
| ASPDYYKRGNFIPGL | 236 | P29803 | |
| GVGYAAVDNPIFYKP | 1046 | Q13423 | |
| FHKPGENYKTPGYVV | 231 | P47897 | |
| KGFSPALQYYTDPLV | 446 | Q9NUP7 | |
| YGKQPDNSPEYSLFV | 86 | Q9NX07 | |
| AYLCGKPDVPIYDGS | 261 | P25325 | |
| QLTVTPDEGYYQGGK | 66 | Q969M7 | |
| GPPSYQKQGSHSVAY | 336 | Q8N5C8 | |
| APEIIAYQPYGKSVD | 506 | P17252 | |
| VYFGPAAAVARGYPK | 91 | Q9C056 | |
| DYTSPGTQKYVGPLK | 551 | Q6P1X5 | |
| YYGEIGIGTPPQTFK | 86 | P00797 | |
| SSPGLGVKYYIDPST | 636 | O15197 | |
| LSPDPKAQYTSIYGA | 76 | Q9NYZ2 | |
| GVYGPKAYVATQGPL | 96 | Q05209 | |
| YLPKDTSPGSAYQEG | 426 | Q99460 | |
| PSAYELPYGTKGSED | 81 | Q11206 | |
| LYPALAKESGYIAPQ | 491 | Q8TF72 | |
| YGTKDPVPGYSVPAA | 231 | P43490 | |
| GGYYQFVIPDLSPKN | 66 | Q96PL2 | |
| YGTLVQEGGSPIKYN | 161 | P55809 | |
| NYVPAPKEGSFELYG | 236 | Q8WVF1 | |
| ALPYKTSASEGNPYV | 311 | Q86SQ0 | |
| SDIGPYQSGRFYTKP | 41 | Q8N474 | |
| GVPPTDDSPKYNYSL | 506 | Q5JTZ9 | |
| TYKPGDNYPVQFIPS | 296 | P35712 | |
| SAVPSPCGKYYTLNG | 231 | P49748 | |
| PQTYSPGEYVCRKGD | 366 | Q8IV77 | |
| AKYPPSQVTRYGDPG | 96 | Q9H3H3 | |
| GYLYGVSPPDNPQVK | 2126 | Q6P2Q9 | |
| GYGSYTPSLKSPNGV | 111 | Q6ZTA4 | |
| SNYGPSIAYQTKSPV | 356 | O94991 | |
| LAKEQGPYETYEGSP | 546 | P23921 | |
| VGTKNYSVSAGDPPV | 786 | Q9NXZ1 | |
| YEAGKAAKAGYPPSV | 236 | Q71H61 | |
| GKQDVYYGVAETSPP | 376 | A1L020 | |
| VDVPSIPSCGKSYGY | 86 | Q8N412 | |
| GPAYYKPQFDVSNAT | 121 | Q8N412 | |
| SPSRSYYANFGVPVK | 1551 | Q9HCF6 | |
| SAKYPAPERLQEYGS | 91 | Q6VEQ5 | |
| SAKYPAPGRLQEYGS | 91 | A8K0Z3 | |
| SIDVNEGGPSYKLPY | 406 | Q9Y263 | |
| EGGPSYKLPYNTSDD | 411 | Q9Y263 | |
| PKSEGYYNVDSGQPS | 161 | Q92753 | |
| ENGPGKADLYSTPQY | 436 | Q9H5I5 | |
| SAKYPAPERLQEYGS | 91 | C4AMC7 | |
| PYKTYSQGAPEAPLS | 426 | Q9P1Z0 | |
| SPKGSEGYLAATYPT | 2496 | P21359 | |
| PGKPGNYQYTVFLRS | 686 | Q9UGP8 | |
| PYANAGKNPDEVSYA | 296 | O95391 | |
| VAYCPSGKPEGLNYA | 2321 | P08922 | |
| TYFNYEAQPDKSGLP | 66 | A0A0K0K1E9 | |
| KAYSDPSTGEPATYG | 3316 | Q15149 | |
| GSGPSYLYGVTQPKH | 26 | Q9UKJ0 | |
| YIEGSEPGKQGTVYA | 196 | Q9BVV7 | |
| PYCPGKTLVVGASYV | 331 | Q86VQ6 | |
| VQKPYGGSGPLYTCV | 986 | O75362 | |
| ITATFLYGYDPKPAG | 306 | Q9Y2D2 | |
| TQGYLKTQGYPDVPG | 26 | Q6UXY8 | |
| LDKQPTDSGGGIYQY | 511 | O60293 | |
| AYIYTKTGSPGPELL | 456 | Q14202 | |
| VTHTSNGPYKGPVYE | 161 | Q9BS34 | |
| TGKNGYIPSNYVAPA | 136 | P07947 | |
| QAVSDPSSPQYGKYL | 66 | O14773 | |
| GKAVTVYTNYPFPGE | 41 | P35573 | |
| NGTDVYQGVPKDYTG | 91 | Q99538 | |
| YQGVPKDYTGEDVTP | 96 | Q99538 | |
| AGASEPKYYSQPILV | 816 | Q00872 |